The Psychedelic Drugs resource page added to the FDA website might be yet another indicator that the regulator is increasingly interested in the field’s potential. In publishing this resource page, which sits alongside one dedicated to drug repurposing, the agency has coalesced July’s finalized guidance for the field and April’s executive order as well as information on its September 2025 Part 15 Hearing, Priority Voucher program, and collaboration with the Department of Veterans Affairs.
